| HOME >> MEDICINE >> TECHNOLOGY |
5.1.2 Revenue 23
5.1.3 Annual Cost of Therapy 26
5.1.4 Treatment Usage Patterns 27
5.2 Injectables 29
5.2.1 Introduction 29
5.2.2 Revenue 29
5.2.3 Annual Cost of Therapy 32
5.2.4 Treatment Usage Patterns 33
5.3 Topical Contraceptives 35
5.3.1 Introduction 35
5.3.2 Revenue 35
5.3.3 Annual Cost of Therapy 38
5.3.4 Treatment Usage Patterns 39
6 Contraceptives Market to 2017 - Devices landscape 41
6.1 Vaginal Ring 41
6.1.1 Introduction 41
6.1.2 Revenue 41
6.1.3 Geographical Segmentation 43
6.1.4 Annual Cost of Usage 45
6.2 Intrauterine Devices 46
6.2.1 Introduction 46
6.2.2 Revenue 46
6.2.3 Copper Intrauterine Device and Hormonal Intrauterine Device Share 47
6.2.4 Geographical Segmentation 48
6.2.5 Annual Cost of Usage 50
6.3 Condoms 51
6.3.1 Introduction 51
6.3.2 Revenue 51
6.3.3 Geographical Segmentation 52
6.3.4 Annual Cost of Usage 54
7 Contraceptives Market to 2017 - Pipeline Analysis 55
7.1 Introduction 55
7.2 Profiles of Promising Drugs in the Global Contraceptives Market 58
7.2.1 AG200-15 58
7.2.2 Yaz Flex 58
7.2.3 Pill-Plus 59
8 Contraceptives Market to 2017 - Competitive Landscape 60
8.1 Market Share Analysis: Contraceptives Market 60
8.2 Drug Profile of Major Marketed Contraceptives 60
8.2.1 Yaz/ Yasmin 61
8.2.2 Mirena 61
8.2.3 Nuvaring 61
8.3 Competitive Profiling 62
8.3.1 Bayer 62
8.3.2 Johnson & Johnson 64
8.3.3 Church & Dwight 65
8.3.4 Merck 66
8.3.5 Reckitt & Benckiser 67
9 Contraceptives Market to 2017 - M&A Landscape 68
9.1 M&A Landscape 68
9.1.1 M&A Deals by Year 68
9.1.2 M&A Deals by Value 69
9.1.3 M&A Deals by Geography 70
9.1.4 M&A
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |